ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 135 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q1 2021. The put-call ratio across all filers is 3.64 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $355,998 | +79.8% | 237,331 | -30.5% | 0.00% | – |
| Q4 2022 | $198,010 | -58.8% | 341,397 | -32.5% | 0.00% | -100.0% |
| Q3 2022 | $481,000 | +32.1% | 505,737 | +145.5% | 0.00% | 0.0% |
| Q4 2021 | $364,000 | -90.6% | 206,022 | -42.5% | 0.00% | -95.2% |
| Q4 2020 | $3,882,000 | +1.9% | 358,166 | -3.1% | 0.02% | -12.5% |
| Q3 2020 | $3,808,000 | – | 369,716 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 3,915,000 | $5,872,500 | 5.39% |
| Versant Venture Management, LLC | 5,068,233 | $7,602,350 | 4.04% |
| Sonic GP LLC | 2,000,000 | $3,000,000 | 2.91% |
| COMMODORE CAPITAL LP | 10,000,000 | $15,000,000 | 1.75% |
| VR Adviser, LLC | 6,573,300 | $9,859,950 | 1.04% |
| AIGH Capital Management LLC | 1,323,985 | $1,985,977 | 0.94% |
| Newtyn Management, LLC | 1,025,000 | $1,537,500 | 0.38% |
| Worth Venture Partners, LLC | 331,668 | $497,502 | 0.30% |
| Acuitas Investments, LLC | 291,169 | $436,754 | 0.26% |
| Quinn Opportunity Partners LLC | 398,298 | $597,447 | 0.08% |